Hypervitaminemia B12 (high level of cobalamin): Physiopathology, role and interest in clinical practice;Hypervitaminémie B12 : Physiopathologie et intérêt en pratique clinique

Presse Medicale

Volumn 40, Issue 12 PART 1, 2011, Pages 1120-1127

  Serraj, Khalid ^a,b   Mecili, Mustapha ^a   Housni, Ibrahim ^b   Andrès, Emmanuel ^a,c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Centre hospitalier universitaire de Oujda   (Morocco)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN;

CLINICAL PRACTICE; CODING; CYANOCOBALAMIN INTOXICATION; DISEASE MARKER; EARLY DIAGNOSIS; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERVITAMINOSIS; LIVER DISEASE; PATHOPHYSIOLOGY; PROGNOSIS; SHORT SURVEY; SOLID TUMOR; VITAMIN BLOOD LEVEL; BIOLOGICAL MODEL; BLOOD; HEMATOLOGIC DISEASE; METABOLIC DISORDER; METABOLISM; NEOPLASM; PHYSIOLOGY; PROFESSIONAL PRACTICE; REVIEW; UPREGULATION;

HEMATOLOGIC DISEASES; HUMANS; LIVER DISEASES; METABOLIC DISEASES; MODELS, BIOLOGICAL; NEOPLASMS; PROFESSIONAL PRACTICE; PROGNOSIS; UP-REGULATION; VITAMIN B 12;

EID: 84856197367     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.08.010     Document Type: Short Survey

References (44)

1. Chiche L., Jean R., Romain F., Roux F., Thomas G., Canavese S., et al. Implications cliniques de la découverte d'une hypervitaminémie B12 en médecine interne. Rev Med Interne 2008, 29:187-194.
2. Chiche L., Molines C., Durand J.M., Helm M. Hypervitaminémie B12 : les métastases ne sont pas loin. Rev Med Interne 2002, 23(Suppl. 1):S40.
3. Deneuville T., Mario N., Tiev K.P., Tolédano C., Josselin-Mahr L., Gain M., et al. Concentration plasmatique élevée de la vitamine B12 : un indicateur des maladies hépatiques ou tumorales ?. Rev Med Interne 2009, 30(Suppl. 2):S73.
4. Chiche L., Mancini J., Arlet J.B. Hypervitaminémies B12 en médecine interne : résultats de l'étude BDOSE. Rev Med interne 2009, 30(Suppl. 4):S377.
5. Andrès E., Vidal-Alaball J., Federici L., Loukili N.H., Zimmer J., Kaltenbach G. Clinical aspects of cobalamin deficiency in elderly patients. Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy. Eur J Intern Med 2007, 18:456-462.
6. Andrès E., Affenberger S., Vinzio S., Noel E., Kaltenbach G., Schlienger J.L. Carences en vitamine B12 chez l'adulte : étiologies, manifestations cliniques et traitement. Rev Med Interne 2005, 26:938-946.
7. Serraj K., Mecili M., Andres E. Signes et symptômes de la carence en vitamine B12 : revue critique de la littérature. Med Ther 2010, 16:13-20.
8. Andrès E., Loukili N.H., Noel E., Kaltenbach G., Ben Abdelgheni M., Perrin A.E., et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004, 171:251-260.
9. Russel R.M. Vitamin requirements in old age. Age Nutr 1992, 3:20-23.
10. Federici L., Henoun Loukili N., Zimmer J., Affenberger S., Maloisel F., Andrès E. Manifestations hématologiques de la carence en vitamine B12 : données personnelles et revue de la littérature. Rev Med Interne 2007, 28:225-231.
11. Ermens A.A., Vlasveld L.T., Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003, 36:585-590.
12. Lindemans J., Kroes A.C.M., van Geel J., Van Kapel J., Schoester M., Abels J. Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction. J Exp Cell Res 1989, 184:449-460.
13. Grasbeck R. Biochemistry and clinical chemistry of vitamin B12 transport and the related diseases. J Clin Biochem 1984, 17:99-107.
14. Nicolas J.P., Gueant J.L., Frémont S. Cobalamin binding glycoproteins. Advances in Thomas Addison's diseases 1994, Journal of Endocrinology Ltd, Bristol, 2:253-67. H.R. Bhatt, V.H.T. James, G.M. Besser, G.F. Bottazzo, H. Keen (Eds.).
15. Zittoun J. Cobalamins: an update of fundamental and clinical data. Hematologie 1996, 2:119-129.
16. Li N., Seetharam S., Lindemans J., Alpers D.H., Arwert F., Seetharam B. Isolation and sequence analysis of variant forms of human transcobalamin II. Biochim Biophys Acta 1993, 1172:21-30.
17. Herbert V. Etiology of vitamin B12 (cobalamin) deficiency and staging of B12 status. Advances in Thomas Addison's diseases 1994, Journal of Endocrinology Ltd, Bristol, 2:139-48. H.R. Bhatt, V.H.T. James, G.M. Besser, G.F. Bottazzo, H. Keen (Eds.).
18. Andrès E., Serraj K., Mecili M., Ciobanu E., Vogel T., Weitten T. Mise au point sur la vitamine B12 administrée par voie orale. Ann Endocrinol 2009, 70:453-461.
19. Solomon L.R. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 2007, 21:113-130.
20. Kanazawa S., Herbert V. Total corrinoid, cobalamin and cobalamin analogue levels may be normal in serum despite cobalamin in liver depletion in patients with alcoholism. Lab Invest 1985, 53:108-110.
21. Baker H., Leevy C.B., DeAngelis B., Frank O., Baker E.R. Cobalamin and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 1998, 17:235-238.
22. Hagelskjaer L., Rasmussen K. Methylmalonic acid concentration in serum not affected in hepatic disease. Clin Chem 1992, 38:493-495.
23. Lambert D., Benhayoun S., Adjalla C., Gélot M.M., Renkes P., Gérard P., et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion 1997, 58:64-71.
24. Carmel R., Eisenberg L. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer 1977, 40:1348-1353.
25. Rain J.D. Intérêt en hématologie du dosage des cobalamines. Immunoanal Biol Spec 1992, 32:17-24.
26. Serraj K., Vogel T., Federici L., Ciobanu E., Mecili M., Kaltenbach G., et al. Le syndrome de non-dissociation de la vitamine B12 de ses protéines porteuses ou de mal digestion des cobalamines alimentaires. Presse Med 2009, 38:55-62.
27. Carmel R. Extreme elevation of serum transcobalamin I in patients with metastatic cancer. N Engl J Med 1975, 292:282-284.
28. Fremont S., Chamigneulle B., Gerard P., Felden P., Lambert D., Gueant J.L., et al. Blood transcobalamin levels in malignant hepatoma. Tumor Biol 1991, 12:353-359.
29. Gimsing P., Hippe E. Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast. Scand J Haematol 1978, 21:243-249.
30. Kane S.P., Murray-Lyon I.M., Paradinas F.J., Johnson P.J., Williams R., Orr H.A., et al. Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma. Gut 1978, 19:1105-1109.
31. Wheeler K., Pritchard J., Luck W., Rossiter M. Transcobalamin I as a marker for fibrolamellar hepatoma. Med Pediatr Oncol 1986, 14:227-229.
32. Gimsing P. Cobalamin metabolism in chronic myelogenous leukemia. Dan Med Bull 1998:459-79.
33. Arnalich F., Zamorano A.F., Martinez-Hernandez P., Pena J.M., Barbado F.J., Vazquez J.J. Additional predictive value of serum unsaturated vitamin B12 proteins in multiple myeloma. J Med 1990, 21:277-286.
34. Vlasveld L.T. Low cobalamin levels in multiple myeloma: a retrospective study. Neth J Med 2003, 61:249-252.
35. Gimsing P. The cobalamin forms and analogues in plasma and myeloid cells during the course of chronic myelogenous leukemia related to the clinical condition. Br J Haematol 1995, 89:812-819.
36. Rachmilewitz B., Manny N., Rachmilewitz M. The transcobalamins in polycythemia vera. Scand J Haematol 1977, 19:453-462.
37. Zittoun J., Farcet J.P., Marquet J., Sultan C., Zittoun R. Cobalamin vitamin B12 (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood 1984, 63:779-783.
38. Rachmilewitz D., Rachmilewitz E.A., Polliack A., Herchko C.A. Acute promyelocytic leukemia. A report of five cases with a comment on the diagnostic significance of serum vitamin B12 determination. Br J Haematol 1972, 22:87-92.
39. Hofer L.J., Elian K.M. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease. Med Clin Exp 2004, 27:10-13.
40. Carmel R., Tatsis B., Baril L. Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood. Blood 1977, 49:987-1000.
41. Reynolds E.H., Bottiglieri T., Laundry M., Stern J., Payan J., Linnell J., et al. Subacute combined degeneration with high serum vitamin B12 level and abnormal vitamin B12 binding protein. Arch Neurol 1993, 50:739-742.
42. Molad Y., Rachmilewitz B., Sidi Y., Pinkhas J., Weinberger A. Serum transcobalamin and transcobalamin levels in systemic lupus erythematosus. Am J Med 1989, 88:141-144.
43. Grindulis K.A., Calverley M., Cox C. Rheumatoid arthritis: is serum vitamin B12 high in active disease?. J Rheumatol 1984, 11:211-212.
44. Zittoun J., Farcet J.P., Marquet J., Sultan C., Zittoun R., Cobalamin B12 binding proteins in hypereosinophilic syndromes and hypereosinophilia. Blood 1984, 63:779-783.